Authors:
Qiu, CB
Qiu, CS
Hess, P
Clozel, JP
Clozel, M
Citation: Cb. Qiu et al., Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure, ACT PHAR SI, 22(6), 2001, pp. 541-548
Authors:
Sutsch, G
Bertel, O
Rickenbacher, P
Clozel, M
Yandle, TG
Nicholls, MG
Kiowski, W
Citation: G. Sutsch et al., Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins, AM J CARD, 85(8), 2000, pp. 973-976
Authors:
Clozel, M
Hess, P
Fischli, W
Loffler, BM
Zwacka, RM
Reuter, A
Weiher, H
Citation: M. Clozel et al., Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease, EXP GERONT, 34(8), 1999, pp. 1007-1015
Authors:
Karam, H
Valdenaire, O
Belair, MF
Prigent-Sassy, C
Rakotosalama, A
Clozel, M
Itskovitz, J
Bruneval, P
Citation: H. Karam et al., The endothelin system in human and monkey ovaries: in situ gene expressionof the different components, CELL TIS RE, 295(1), 1999, pp. 101-109
Authors:
Clozel, M
Qiu, CB
Osterwalder, R
Roeckel, A
Bruneval, P
Heudes, D
Clozel, JP
Citation: M. Clozel et al., Effects of nonpeptide endothelin receptor antagonists in rats with reducedrenal mass, J CARDIO PH, 33(4), 1999, pp. 611-618
Authors:
Clozel, M
Ramuz, H
Clozel, JP
Breu, V
Hess, P
Loffler, BM
Coassolo, P
Roux, S
Citation: M. Clozel et al., Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J PHARM EXP, 290(2), 1999, pp. 840-846